LB Pharmaceuticals Inc (LBRX) stock
LBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$38.85−1.19 (-2.97%)
Close on Nov 20, 2026Market cap $1.25BP/E –Yield –
LB Pharmaceuticals free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
LB Pharmaceuticals's free cash flow for the twelve months ending Jun 30, 2026 was -$82.83M. For fiscal 2025 it was -$35.26M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$35.26M | – |
| FY2024 | Dec 31, 2024 | -$53.82M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$37.99M | – |
| Q1 FY2026 | Mar 31, 2026 | -$23.32M | – |
| Q4 FY2025 | Dec 31, 2025 | -$18.14M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.37M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.60M | – |
| Q1 FY2025 | Mar 31, 2025 | -$8.15M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.90M | – |
See a number that looks wrong?